SAPHO syndrome

Revision as of 17:19, 29 March 2018 by Medhat (talk | contribs)
Jump to navigation Jump to search
SAPHO syndrome
DiseasesDB 30718

WikiDoc Resources for SAPHO syndrome

Articles

Most recent articles on SAPHO syndrome

Most cited articles on SAPHO syndrome

Review articles on SAPHO syndrome

Articles on SAPHO syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on SAPHO syndrome

Images of SAPHO syndrome

Photos of SAPHO syndrome

Podcasts & MP3s on SAPHO syndrome

Videos on SAPHO syndrome

Evidence Based Medicine

Cochrane Collaboration on SAPHO syndrome

Bandolier on SAPHO syndrome

TRIP on SAPHO syndrome

Clinical Trials

Ongoing Trials on SAPHO syndrome at Clinical Trials.gov

Trial results on SAPHO syndrome

Clinical Trials on SAPHO syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on SAPHO syndrome

NICE Guidance on SAPHO syndrome

NHS PRODIGY Guidance

FDA on SAPHO syndrome

CDC on SAPHO syndrome

Books

Books on SAPHO syndrome

News

SAPHO syndrome in the news

Be alerted to news on SAPHO syndrome

News trends on SAPHO syndrome

Commentary

Blogs on SAPHO syndrome

Definitions

Definitions of SAPHO syndrome

Patient Resources / Community

Patient resources on SAPHO syndrome

Discussion groups on SAPHO syndrome

Patient Handouts on SAPHO syndrome

Directions to Hospitals Treating SAPHO syndrome

Risk calculators and risk factors for SAPHO syndrome

Healthcare Provider Resources

Symptoms of SAPHO syndrome

Causes & Risk Factors for SAPHO syndrome

Diagnostic studies for SAPHO syndrome

Treatment of SAPHO syndrome

Continuing Medical Education (CME)

CME Programs on SAPHO syndrome

International

SAPHO syndrome en Espanol

SAPHO syndrome en Francais

Business

SAPHO syndrome in the Marketplace

Patents on SAPHO syndrome

Experimental / Informatics

List of terms related to SAPHO syndrome

CEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Acquired hyperostosis syndrome

Overview

SAPHO syndrome is thought to comprise a spectrum of disorders that share some clinical, radiologic and pathologic characteristics. An entity known as chronic recurrent multifocal osteomyelitis (CRMO) was first described in 1972. Subsequently in 1978 several cases of CRMO were associated with clinical findings of palmoplantar pustulosis. Since then, a number of associations between skin conditions and osteoarticular disorders have been reported with a variety of different names including sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, and acne-associated spondyloarthropathy. SAPHO was coined in 1987 and basically represents a spectrum of inflammatory osteitis which may or may not be associated with dermatologic pathology.

Definition

Etiology

  • The etiology is still unknown [2]. The pathogenesis involves a combination of genetic and immunological components.
  • HLA-B27 is more frequent in SAPHO.

Chromosome 18 plays a role in the SAPHO syndrome. LPIN2 and NOD2. LPIN2 encodes lipin 2, which is involved in modulating

apoptosis of polymorphonuclear cells, and mutations of the

NOD2 gene may lead to an abnormal immune response to

bacterial peptidoglycans via activation of the proinflammatory

transcription factor nuclear factor kappa B [19].

There are also hypotheses of infectious disease, suggesting

that bone lesions are caused by a low-virulence

pathogen [2, 13]. Different types of pathogens were isolated

from different bone sites and pustules in the skin,

including Staphylococcus aureus [20], Haemophilus parainfluenzae,

and Actinomyces, as well as Treponema

pallidum, Veillonella, and Eikenella [21]. The most

important is Propionibacterium acnes, which is identified

more often, but positive cultures can only be seen in a

small number of total bone biopsy specimens. The largest

number of P. acnes-positive biopsy specimens was proved

by Assmann and Simon [2] in their study of 21 SAPHO

patients, where 67 % of them were positive. This infectious

hypothesis is supported by increased levels of circulating

IgA in these patients and there is also evidence that intraarticular

injection of inactivated P. acnes in rats can cause

erosive joint lesions. On the other hand, according to some

of the latest considerations, since P. acnes is found in only

two-thirds of biopsies at most and the treatment with

antibiotics is effective only for as long as it is taken, it is

considered that SAPHO cannot be classified among

infections, even due to latent organisms [22–24].

There are various reports on immune system dysfunction

in SAPHO [25–29]. According to some of them,

humoral immune response is hyperactive and in others, it is

hypoactive. This is similar to the cell-mediated immune

response that has been reported as normal or hyperactive;

total immune system impairment has been reported as well

[28]. Hurtado-Nedelec et al. showed that SAPHO is characterized

by elevated IL-8 and IL-18 levels. They had not

detect any autoantibodies among their SAPHO patients,

including rheumatoid factor, anti-CCP2, or antinuclear

antibodies. IL-8 and TNFa production by purified polymorphonuclear

leukocytes (PMN) were elevated in these

patients compared to the controls, but the oxidative burst

and IL-18 production were normal. They also showed that,

after 28 days of etanercept therapy, PMN, IL-8, and TNFa

Differential diagnosis

SAPHO must be differentiated from other diseases that cause bone pain, edema, and erythema.

Disease Findings
Soft tissue infection
(Commonly cellulitis)
History of skin warmness, swelling and erythema. Bone probing is the definite way to differentiate them.[1][2]
Osteonecrosis
(Avascular necrosis of bone)
Previous history of trauma, radiation, use of steroids or biphosphonates are suggestive to differentiate osteonecrosis from ostemyelitis.[3][4]
MRI is diagnostic.[5][6]
Charcot joint Patients with Charcot joint commonly develop skin ulcerations that can in turn lead to secondary osteomyelitis.
Contrast-enhanced MRI may be diagnostically useful if it shows a sinus tract, replacement of soft tissue fat, a fluid collection, or extensive marrow abnormalities. Bone biopsy is the definitive diagnostic modality.[7]
Bone tumors May present with local pain and radiographic changes consistent with osteomyelitis.
Tumors most likely to mimic osteomyelitis are osteoid osteomas and chondroblastomas that produce small, round, radiolucent lesions on radiographs.[8]
Gout Gout presents with joint pain and swelling. Joint aspiration and crystals in synovial fluid is diagnostic for gout.[9]
SAPHO syndrome
(Synovitis, acne, pustulosis, hyperostosis, and osteitis)
SAPHO syndrome consists of a wide spectrum of neutrophilic dermatosis associated with aseptic osteoarticular lesions.
It can mimic osteomyelitis in patients who lack the characteristic findings of pustulosis and synovitis.
The diagnosis is established via clinical manifestations; bone culture is sterile in the setting of osteitis.
Sarcoidosis It involves most frequently the pulmonary parenchyma and mediastinal lymph nodes, but any organ system can be affected.
Bone involvement is often bilateral and bones commonly affected include the middle and distal phalanges (producing “sausage finger”), wrist, skull, vertebral column, and long bones.
Langerhans' cell histiocytosis The disease usually manifests in the skeleton and solitary bone lesions are encountered twice as often as multiple bone lesions.
The tumours can develop in any bone, but most commonly originate in the skull and jaw, followed by vertebral bodies, ribs, pelvis, and long bones.[10]

Radiologic Findings

Anterior chest wall (most common site, 65-90% of pts): Hyperostosis, sclerosis and bone hypertrophy especially involving the sternoclavicular joint, often with a soft tissue component.

Above images demonstrate sclerosis and hyperostosis of the medial left clavicle (sternocostoclavicular hyperostosis), a very typical site of involvement in the SAPHO syndrome.

Spine (second most common site, 33% of pts): Segmental, usually involving the thoracic spine. 4 main presentations include spondylodiscitis, osteosclerosis, paravertebral ossifications, and sacroiliac joint involvement.

Long bones (30% of pts): usually metadiaphyseal and located in the distal femur and proximal tibia. It looks like chronic osteomyelitis but will not have a sequestrum or abscess.

Flat bones: mandible and ilium (10% of pts).

Peripheral arthritis has been reported in 92% of cases of SAPHO as well.

Children: There is a predilection for the metaphysis of long bones in the legs (tibia, femur, fibula), followed by clavicles and spine.

Treatment

Treatment of patients with SAPHO syndrome is based on clinical symptoms. Generally, treatment involves non-steroidal antiinflammatory drugs and corticosteroid medications (either in the form of topical creams, tablets, or by injection into the involved area). Topical cold applications may also help in affected areas. If unsuccessful, both sulfasalazine and methotrexate have been tried with mixed results.

References



Template:WikiDoc Sources

  1. Bisno AL, Stevens DL (1996). "Streptococcal infections of skin and soft tissues". N. Engl. J. Med. 334 (4): 240–5. doi:10.1056/NEJM199601253340407. PMID 8532002.
  2. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin. Infect. Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.
  3. Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, Ochiai N, Takahashi K (2011). "Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study". Rheumatology (Oxford). 50 (11): 2023–8. doi:10.1093/rheumatology/ker277. PMID 21865285.
  4. Slobogean GP, Sprague SA, Scott T, Bhandari M (2015). "Complications following young femoral neck fractures". Injury. 46 (3): 484–91. doi:10.1016/j.injury.2014.10.010. PMID 25480307.
  5. Amanatullah DF, Strauss EJ, Di Cesare PE (2011). "Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management". Am J. Orthop. 40 (9): E186–92. PMID 22022684.
  6. Etienne G, Mont MA, Ragland PS (2004). "The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head". Instr Course Lect. 53: 67–85. PMID 15116601.
  7. Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP (2006). "Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics". Radiology. 238 (2): 622–31. doi:10.1148/radiol.2382041393. PMID 16436821.
  8. Lovell, Wood (2014). Lovell and Winter's pediatric orthopaedics. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-1605478142.
  9. Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW (2010). "Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis". Arthritis Rheum. 62 (11): 3237–48. doi:10.1002/art.27667. PMC 2970687. PMID 20662061.
  10. Picarsic J, Jaffe R (2015). "Nosology and Pathology of Langerhans Cell Histiocytosis". Hematol. Oncol. Clin. North Am. 29 (5): 799–823. doi:10.1016/j.hoc.2015.06.001. PMID 26461144.